FRGT vs MASK

FRGT exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic 95.2% price decline over the last year. The company suffers from negative gross margins (-24.43%), meaning it loses money on every unit sold, which renders traditional valuation metrics like the Graham Number inapplicable. While revenue growth is positive at 30.2%, it is insufficient to offset massive operating losses and a deteriorating liquidity position (Current Ratio 0.94). The stock is currently in a freefall, trading near its 52-week low after a collapse from $69.80.

MASK presents a classic 'value trap' scenario; while the Piotroski F-Score of 6/9 indicates stable financial health and the Graham Number ($30.61) suggests massive undervaluation, the market is pricing the stock at a catastrophic discount. The discrepancy between the intrinsic value ($24.50) and the current price ($1.79) is too extreme to be a mere inefficiency, likely reflecting systemic risks or a total loss of investor confidence. With a technical trend of 0/100 and a 1-year price collapse of 97.8%, the fundamental strengths are completely decoupled from market reality.